Pulmonary Embolism Pretest Probability
Overview and clinical purpose
The purpose of pulmonary embolism pretest probability is to connect a clinical question with a defensible interpretation and an appropriate response. The clinical scope in this manuscript is respiratory medicine. The approach considers both routine encounters and presentations in which new symptoms, acute physiological changes or important comorbid conditions alter urgency. No single test or observation should be treated as a complete diagnostic assessment.
This guide is intended for healthcare professionals who need to organise an assessment, explain uncertainty and recognise when an apparently routine presentation needs urgent attention. It does not replace direct examination or the current pathway used by the treating service. In pulmonary embolism pretest probability, an important practical example is suspected PE can present with shock, syncope, severe hypoxaemia or circulatory collapse requiring immediate care. Risk stratification for an unstable patient differs from routine testing of a stable ambulatory patient.
A useful decision process begins with the clinical question and the person’s current condition. The meaning of a test, symptom or score depends on timing, population, technical limitations and the consequences of an incorrect decision. A deliberately transparent assessment is usually safer than applying a number without context. In pulmonary embolism pretest probability, an important practical example is revised Geneva and other validated tools offer alternatives in particular settings. Different rules and versions produce different categories and may not share identical diagnostic thresholds.
The sections below link practical findings to interpretation and safe follow-up. Worked examples are hypothetical reasoning exercises; they are not clinical case reports, validated algorithms or instructions to administer treatment without supervision. In pulmonary embolism pretest probability, an important practical example is cT pulmonary angiography is commonly used to confirm or exclude PE in appropriate patients. Renal dysfunction, contrast allergy and radiation considerations may favour ventilation–perfusion imaging in selected situations.
Clinical basis and initial framing
Clinical stability first
Suspected PE can present with shock, syncope, severe hypoxaemia or circulatory collapse requiring immediate care. Risk stratification for an unstable patient differs from routine testing of a stable ambulatory patient. In practice, this finding should be placed on a timeline rather than entered as an isolated data point. The history of symptoms, previous investigations and current physiological state can change how much importance the observation deserves. Describe both the finding itself and the question it is meant to answer.
Assess airway, breathing, circulation, oxygenation and haemodynamics before using diagnostic exclusion algorithms. Do not allow a calculated low-risk label to delay treatment of a patient with shock. Where the result differs from expectation, reassessment begins by checking the input information, possible alternative explanations and the person’s current condition. A structured clinical note distinguishes observations from conclusions and avoids a certainty that the available evidence cannot support.
Symptoms and signs
Sudden dyspnoea, pleuritic chest pain, haemoptysis, tachycardia or leg symptoms may contribute to clinical suspicion. None of these findings is specific, and a person with PE can lack classic symptoms. Clinical reasoning is stronger when the team records why this feature was sought and how it changes the working assessment. Symptoms, measurements and laboratory data may relate to overlapping conditions. Compare with a credible baseline and avoid separating the value from the patient in whom it was measured.
Integrate symptom onset, examination and competing explanations before assigning pretest probability. A normal chest radiograph or non-specific ECG does not rule out pulmonary embolism. The next decision must be explicit: whether more information is needed, whether supervision or specialist help is warranted, and when the patient should be reassessed. The reason for not acting is often as important to document as the reason for intervention.
Provoking factors
Recent surgery, immobility, malignancy, previous VTE, hormonal exposure and pregnancy may increase risk. Risk is modified by duration, severity and combinations of factors rather than by a single binary history. A useful interpretation asks whether this observation is reproducible, whether it is new and whether it has occurred during an acute change in health. Results collected under different conditions may not be directly comparable. Treat uncertainty as information to be managed rather than concealed.
Document relevant risk exposures and integrate them into the appropriate validated decision rule. Do not treat an isolated risk factor as proof of embolism without a clinical assessment. Decisions should be proportional to the potential consequence of delay. When signs are discordant, describe the disagreement and identify the examination or investigation that can resolve it safely. Avoid turning a risk indicator into a definitive diagnosis without supportive evidence.
Clinical history and risk context
Two-level Wells score
The two-level PE Wells approach classifies presentations into PE likely and PE unlikely groups. The rule includes subjective assessment of whether an alternative diagnosis is less likely than PE. The clinical meaning of this feature depends on who was tested, why it was tested and what was happening at the time. A reference interval or guideline statement is not a substitute for reviewing comorbidity, treatments and the reliability of the observation.
Apply the rule using exact published definitions and document the total and clinical context. Do not substitute the DVT Wells score or mix items from different PE scores. Subsequent review should consider trajectory as well as threshold. Record what would count as an important change, what competing explanation remains possible and who has responsibility for the next result or bedside reassessment.
Other probability models
Revised Geneva and other validated tools offer alternatives in particular settings. Different rules and versions produce different categories and may not share identical diagnostic thresholds. The distinction between an associated feature and a causal diagnosis matters here. One abnormality may reflect several processes, while several mild abnormalities together may indicate deterioration. Patient safety depends on assessing the pattern and not merely the most conspicuous number.
Choose the pathway used and validated by the local service and apply it consistently. Combining a Wells score with an unrelated cut-off may invalidate the exclusion strategy. Discuss the interpretation in language appropriate for the setting. A clear handover includes the degree of uncertainty, the immediate safety concern if any, the intended test or review, and a route for rapid escalation if the patient worsens.
PERC for very low risk
The pulmonary embolism rule-out criteria may reduce testing in carefully selected patients with very low clinical suspicion. PERC is not intended to replace formal assessment of a patient whose clinical suspicion is moderate or high. In practice, this finding should be placed on a timeline rather than entered as an isolated data point. The history of symptoms, previous investigations and current physiological state can change how much importance the observation deserves. Describe both the finding itself and the question it is meant to answer.
Confirm that the patient is within the population for which the rule is appropriate and that all criteria are met. Do not calculate PERC after a high-risk presentation merely to avoid indicated testing. Where the result differs from expectation, reassessment begins by checking the input information, possible alternative explanations and the person’s current condition. A structured clinical note distinguishes observations from conclusions and avoids a certainty that the available evidence cannot support.
Examination, monitoring and interpretation
D-dimer purpose
A sensitive D-dimer may help exclude PE when pretest probability and the assay support a validated rule-out pathway. D-dimer becomes less specific with age, inflammation, malignancy, pregnancy and recent surgery. Clinical reasoning is stronger when the team records why this feature was sought and how it changes the working assessment. Symptoms, measurements and laboratory data may relate to overlapping conditions. Compare with a credible baseline and avoid separating the value from the patient in whom it was measured.
Interpret a negative test only in the right probability group and using the correct assay and units. A positive D-dimer is not proof of PE, and a negative result is insufficient in a high-probability pathway. The next decision must be explicit: whether more information is needed, whether supervision or specialist help is warranted, and when the patient should be reassessed. The reason for not acting is often as important to document as the reason for intervention.
Age-adjusted threshold
Selected adult pathways use age-adjusted D-dimer cut-offs for people older than 50 years. The threshold must match the assay units and validated testing strategy. A useful interpretation asks whether this observation is reproducible, whether it is new and whether it has occurred during an acute change in health. Results collected under different conditions may not be directly comparable. Treat uncertainty as information to be managed rather than concealed.
Check whether the local protocol uses conventional, age-adjusted or another validated threshold. Do not switch units from FEU to DDU without accounting for the difference. Decisions should be proportional to the potential consequence of delay. When signs are discordant, describe the disagreement and identify the examination or investigation that can resolve it safely. Avoid turning a risk indicator into a definitive diagnosis without supportive evidence.
Imaging selection
CT pulmonary angiography is commonly used to confirm or exclude PE in appropriate patients. Renal dysfunction, contrast allergy and radiation considerations may favour ventilation–perfusion imaging in selected situations. The clinical meaning of this feature depends on who was tested, why it was tested and what was happening at the time. A reference interval or guideline statement is not a substitute for reviewing comorbidity, treatments and the reliability of the observation.
Discuss scan choice, image availability and interim management with the responsible clinical team. A poor-quality scan should not be reported to the patient as a definitive negative without reviewing limitations. Subsequent review should consider trajectory as well as threshold. Record what would count as an important change, what competing explanation remains possible and who has responsibility for the next result or bedside reassessment.
Investigation choices and competing explanations
Pregnancy and postpartum
Pregnancy and the period after birth change disease prevalence, laboratory findings and imaging considerations. Adult outpatient rule-out tools may not be validated in these populations. The distinction between an associated feature and a causal diagnosis matters here. One abnormality may reflect several processes, while several mild abnormalities together may indicate deterioration. Patient safety depends on assessing the pattern and not merely the most conspicuous number.
Apply an appropriate obstetric VTE pathway with multidisciplinary input and balanced imaging decisions. Do not simply transpose a generic nonpregnant adult D-dimer rule into postpartum care. Discuss the interpretation in language appropriate for the setting. A clear handover includes the degree of uncertainty, the immediate safety concern if any, the intended test or review, and a route for rapid escalation if the patient worsens.
Cancer and hospital setting
Active cancer and inpatient illness raise the prevalence of VTE and can reduce the usefulness of D-dimer exclusion. The balance between unnecessary imaging and missed embolism differs from low-risk outpatient care. In practice, this finding should be placed on a timeline rather than entered as an isolated data point. The history of symptoms, previous investigations and current physiological state can change how much importance the observation deserves. Describe both the finding itself and the question it is meant to answer.
Use setting-specific probability assessments and consider treatment and bleeding risks together. A test pathway validated in healthy outpatients may have poor performance in hospitalised patients. Where the result differs from expectation, reassessment begins by checking the input information, possible alternative explanations and the person’s current condition. A structured clinical note distinguishes observations from conclusions and avoids a certainty that the available evidence cannot support.
Interim anticoagulation
When imaging is delayed, validated guidelines may advise interim anticoagulation for selected suspected VTE cases. The decision requires consideration of bleeding risk, alternative diagnoses and test availability. Clinical reasoning is stronger when the team records why this feature was sought and how it changes the working assessment. Symptoms, measurements and laboratory data may relate to overlapping conditions. Compare with a credible baseline and avoid separating the value from the patient in whom it was measured.
Follow the actual NICE or local pathway and document the clinical reasoning and re-evaluation plan. Do not treat interim therapy as a substitute for establishing or refuting the diagnosis. The next decision must be explicit: whether more information is needed, whether supervision or specialist help is warranted, and when the patient should be reassessed. The reason for not acting is often as important to document as the reason for intervention.
Escalation, follow-up and communication
Risk after diagnosis
Confirmed PE severity assessment is different from estimating probability before diagnostic testing. Right ventricular dysfunction, haemodynamics and biomarkers help risk-stratify confirmed disease. A useful interpretation asks whether this observation is reproducible, whether it is new and whether it has occurred during an acute change in health. Results collected under different conditions may not be directly comparable. Treat uncertainty as information to be managed rather than concealed.
Keep diagnostic pretest probability separate from postdiagnosis prognosis and treatment planning. Do not confuse a low Wells probability with low severity if PE is ultimately confirmed. Decisions should be proportional to the potential consequence of delay. When signs are discordant, describe the disagreement and identify the examination or investigation that can resolve it safely. Avoid turning a risk indicator into a definitive diagnosis without supportive evidence.
Clinical reassessment
New hypotension, increasing hypoxia or syncope can change the patient from a routine investigation to emergency care. Probability estimates should be revisited when important new clinical findings appear. The clinical meaning of this feature depends on who was tested, why it was tested and what was happening at the time. A reference interval or guideline statement is not a substitute for reviewing comorbidity, treatments and the reliability of the observation.
Repeat observations and escalate when trajectory or new data change the assessment. Do not assume the original score remains valid through significant deterioration. Subsequent review should consider trajectory as well as threshold. Record what would count as an important change, what competing explanation remains possible and who has responsibility for the next result or bedside reassessment.
Discharge communication
A negative validated pathway leaves room for other explanations and future new symptoms. Patients should understand the finding, the limits of the test and the next steps for persistent symptoms. The distinction between an associated feature and a causal diagnosis matters here. One abnormality may reflect several processes, while several mild abnormalities together may indicate deterioration. Patient safety depends on assessing the pattern and not merely the most conspicuous number.
Give clear red flags and document the alternative diagnoses considered and investigation follow-up. A negative workup today cannot promise that a later clot or different illness will never occur. Discuss the interpretation in language appropriate for the setting. A clear handover includes the degree of uncertainty, the immediate safety concern if any, the intended test or review, and a route for rapid escalation if the patient worsens.
Evidence and clinical application
NICE two-level Wells must be applied faithfully
NICE NG158 classifies PE as likely when the two-level Wells score is greater than 4 and unlikely when it is 4 or less. The score includes signs of DVT, heart rate over 100, recent immobilisation or surgery, previous VTE, haemoptysis, malignancy and the clinician’s judgement about competing diagnoses. The latter component requires deliberate reflection rather than automatic scoring. A PE-likely classification generally directs the clinician toward prompt appropriate imaging, while a PE-unlikely classification can lead to D-dimer testing under the guideline. The score is not a stand-alone diagnosis and does not replace resuscitation in unstable patients.
The role and limits of PERC
Pulmonary embolism rule-out criteria were designed for carefully selected presentations with low overall clinical suspicion. They should not be used as a workaround after a clinician has already established moderate or high probability. NICE suggests considering PERC when suspicion is low and other diagnoses are feasible. The criteria must be checked in full, with attention to age, oxygen saturation, heart rate, VTE history and other clinical features. There are important populations in which evidence is limited, so a clinician should use the validated local pathway. A negative PERC assessment is meaningful only when entry criteria were met.
D-dimer can exclude but does not diagnose
A sensitive D-dimer test may support PE exclusion in a patient whose pretest probability is sufficiently low, but a positive result is nonspecific. Infection, surgery, pregnancy, cancer and age can elevate it without a clot. The test should be interpreted with the correct units and threshold, and NICE allows consideration of age-adjusted thresholds for people older than 50. For a high-probability presentation, a negative D-dimer is not a reliable alternative to indicated imaging. The safety of exclusion depends on applying the entire validated strategy rather than cherry-picking the apparently reassuring component.
Selecting an imaging pathway
CT pulmonary angiography is commonly used when the clinical pathway calls for definitive imaging. Patients with severe contrast allergy, major renal impairment or particular radiation concerns may be better served by an appropriate ventilation–perfusion study, depending on facilities. The decision involves timing, anticipated diagnostic quality, pregnancy status and the patient’s stability. A report may describe a technically limited examination, which should prompt clinical correlation instead of being treated as a conclusive negative. A delay in imaging may also require consideration of interim anticoagulation under local guidance, taking bleeding risk into account.
Two different meanings of risk
Pretest probability answers whether PE is likely to be present before confirmatory testing. Once PE is diagnosed, a separate prognostic assessment considers haemodynamic stability, right ventricular strain and other markers that influence severity and management. A patient initially categorised as PE-unlikely can still be critically ill if a clot is ultimately found, just as a PE-likely score does not prove severe disease. Confusing these stages may lead to incorrect communication or treatment decisions. Record the diagnostic classification and subsequent severity assessment as separate conclusions with their own evidence.
Safe discharge after exclusion
A patient with a correctly applied negative rule-out strategy may not need further PE testing, but persistent chest pain, breathlessness or faintness can still require investigation for other causes. Explain which diagnosis was considered, how it was assessed and the symptoms that warrant returning urgently. If a scan was inconclusive or results remain pending, assign responsibility for follow-up rather than presenting the workup as completed. A decision made today does not guarantee absence of a new event in the future. Clear safety-net advice is therefore a part of high-quality diagnostic care, not an optional add-on.
Illustrative clinical reasoning scenarios
Scenario 1: Baseline assessment and changing findings
Consider an illustrative assessment in which suspected PE can present with shock, syncope, severe hypoxaemia or circulatory collapse requiring immediate care. At the same time, another element of the history or results introduces a complication: the rule includes subjective assessment of whether an alternative diagnosis is less likely than PE. The first task is to decide which of these findings is directly observed and which is an inference dependent on context. This matters because an apparent clinical pattern can change when timing, test quality or baseline physiology becomes clearer.
A careful response would include the following consideration: Check whether the local protocol uses conventional, age-adjusted or another validated threshold. An important error to avoid in this situation is that do not allow a calculated low-risk label to delay treatment of a patient with shock. This is an illustrative reasoning exercise rather than a treatment protocol. First establish the acuity of the presentation and what is known from a reliable history. Ask which observations change the probability of a serious problem, and which might be confounded by a concurrent condition. A safe plan needs both an immediate action and a later review point.
Scenario 2: A normal-looking result that needs context
Consider an illustrative assessment in which recent surgery, immobility, malignancy, previous VTE, hormonal exposure and pregnancy may increase risk. At the same time, another element of the history or results introduces a complication: pERC is not intended to replace formal assessment of a patient whose clinical suspicion is moderate or high. The first task is to decide which of these findings is directly observed and which is an inference dependent on context. This matters because an apparent clinical pattern can change when timing, test quality or baseline physiology becomes clearer.
A careful response would include the following consideration: Apply an appropriate obstetric VTE pathway with multidisciplinary input and balanced imaging decisions. An important error to avoid in this situation is that do not treat an isolated risk factor as proof of embolism without a clinical assessment. The important distinction is between a feature that raises suspicion and evidence that confirms the diagnosis. If the apparent result conflicts with the patient’s presentation, confirm quality and timing before changing care. Escalate promptly if new physiological instability, progressive symptoms or another major warning sign appears.
Scenario 3: When a second finding changes the pathway
Consider an illustrative assessment in which revised Geneva and other validated tools offer alternatives in particular settings. At the same time, another element of the history or results introduces a complication: the threshold must match the assay units and validated testing strategy. The first task is to decide which of these findings is directly observed and which is an inference dependent on context. This matters because an apparent clinical pattern can change when timing, test quality or baseline physiology becomes clearer.
A careful response would include the following consideration: Follow the actual NICE or local pathway and document the clinical reasoning and re-evaluation plan. An important error to avoid in this situation is that combining a Wells score with an unrelated cut-off may invalidate the exclusion strategy. A useful handover separates three elements: observations that have been established, inferences that remain tentative and decisions awaiting further data. This avoids giving the receiving team an unjustified sense of certainty. State what needs repeating, who is responsible and what deterioration would trigger urgent reassessment.
Scenario 4: Reassessing the initial diagnostic impression
Consider an illustrative assessment in which a sensitive D-dimer may help exclude PE when pretest probability and the assay support a validated rule-out pathway. At the same time, another element of the history or results introduces a complication: adult outpatient rule-out tools may not be validated in these populations. The first task is to decide which of these findings is directly observed and which is an inference dependent on context. This matters because an apparent clinical pattern can change when timing, test quality or baseline physiology becomes clearer.
A careful response would include the following consideration: Repeat observations and escalate when trajectory or new data change the assessment. An important error to avoid in this situation is that a positive D-dimer is not proof of PE, and a negative result is insufficient in a high-probability pathway. For a patient whose first assessment is reassuring, consider whether the proposed exclusion pathway is actually valid in this population. Ask whether the test or examination was performed at an informative time and whether a competing diagnosis has been assessed. The advice at discharge must address changing symptoms rather than only the initial measurement.
Scenario 5: Making a defensible follow-up plan
Consider an illustrative assessment in which cT pulmonary angiography is commonly used to confirm or exclude PE in appropriate patients. At the same time, another element of the history or results introduces a complication: the decision requires consideration of bleeding risk, alternative diagnoses and test availability. The first task is to decide which of these findings is directly observed and which is an inference dependent on context. This matters because an apparent clinical pattern can change when timing, test quality or baseline physiology becomes clearer.
A careful response would include the following consideration: Assess airway, breathing, circulation, oxygenation and haemodynamics before using diagnostic exclusion algorithms. An important error to avoid in this situation is that a poor-quality scan should not be reported to the patient as a definitive negative without reviewing limitations. A decision-support document should not automatically escalate every unusual result, but it must not minimise important clinical context. Consider the seriousness of an error in each direction and explain which findings would alter the balance. Where several pathways could apply, use one internally consistent evidence-based pathway.
Scenario 6: Escalating an unexpected clinical trajectory
Consider an illustrative assessment in which active cancer and inpatient illness raise the prevalence of VTE and can reduce the usefulness of D-dimer exclusion. At the same time, another element of the history or results introduces a complication: probability estimates should be revisited when important new clinical findings appear. The first task is to decide which of these findings is directly observed and which is an inference dependent on context. This matters because an apparent clinical pattern can change when timing, test quality or baseline physiology becomes clearer.
A careful response would include the following consideration: Document relevant risk exposures and integrate them into the appropriate validated decision rule. An important error to avoid in this situation is that a test pathway validated in healthy outpatients may have poor performance in hospitalised patients. Repeated assessment often adds information that a single snapshot cannot provide. Compare measurements under similar conditions, account for treatments given between observations and describe any new symptoms. The follow-up plan should not rely on the patient independently interpreting a laboratory result without clinical advice.
Scenario 7: Reconciling conflicting signals
Consider an illustrative assessment in which confirmed PE severity assessment is different from estimating probability before diagnostic testing. At the same time, another element of the history or results introduces a complication: risk stratification for an unstable patient differs from routine testing of a stable ambulatory patient. The first task is to decide which of these findings is directly observed and which is an inference dependent on context. This matters because an apparent clinical pattern can change when timing, test quality or baseline physiology becomes clearer.
A careful response would include the following consideration: Choose the pathway used and validated by the local service and apply it consistently. An important error to avoid in this situation is that do not confuse a low Wells probability with low severity if PE is ultimately confirmed. When a measurement is unreliable, substituting a more accurate test may be more useful than collecting repeated unreliable values. Assess the technical method, biological factors and whether the result is plausible in light of the examination. Avoid treating a number as an objective fact without considering how it was obtained.
Scenario 8: Safe handover when information remains incomplete
Consider an illustrative assessment in which a negative validated pathway leaves room for other explanations and future new symptoms. At the same time, another element of the history or results introduces a complication: risk is modified by duration, severity and combinations of factors rather than by a single binary history. The first task is to decide which of these findings is directly observed and which is an inference dependent on context. This matters because an apparent clinical pattern can change when timing, test quality or baseline physiology becomes clearer.
A careful response would include the following consideration: Interpret a negative test only in the right probability group and using the correct assay and units. An important error to avoid in this situation is that a negative workup today cannot promise that a later clot or different illness will never occur. The best next action may be to seek specialist interpretation, particularly when a result is borderline or the consequences of an incorrect conclusion are high. Document why advice was requested, the recommendation received and the review arrangements. Do not claim that a preliminary classification excludes all future deterioration.
Documentation and clinical handover
For pulmonary embolism pretest probability, a clinical record should state the reason for assessment, the relevant history and observed findings, the clinical decision reached and important alternative explanations. Include measurement units, collection times and source of any baseline when these affect interpretation. A named clinician or service should be responsible for follow-up of results that are not available when the patient leaves the clinical area.
In pulmonary embolism pretest probability, the purpose of a safety net is to make deterioration recognisable and to ensure that a person knows where to seek help. Use plain language for patients, specify the symptoms that should prompt urgent review and ensure that clinical staff have access to the reasoning behind the initial decision. When an unexpected result appears, reassess the patient rather than simply updating a score.
Practical questions and answers
What should be established before applying a clinical pathway?
Sudden dyspnoea, pleuritic chest pain, haemoptysis, tachycardia or leg symptoms may contribute to clinical suspicion. Start by defining the patient population, the diagnostic or monitoring purpose and the urgency of the presentation. The same result may carry different significance in a stable outpatient and in a patient with progressive physiological compromise. Use the current local pathway for the clinical setting. In this context, integrate symptom onset, examination and competing explanations before assigning pretest probability.
Can a reassuring initial result exclude a serious condition?
The two-level PE Wells approach classifies presentations into PE likely and PE unlikely groups. An apparently reassuring value cannot always exclude an important condition. Check test performance, timing, biological variability and whether the patient belongs to the population in which the threshold was validated. Persisting red flags require reassessment irrespective of one result. In this context, apply the rule using exact published definitions and document the total and clinical context.
Which findings should prompt escalation?
The pulmonary embolism rule-out criteria may reduce testing in carefully selected patients with very low clinical suspicion. Escalation should follow the severity and direction of clinical change as well as the absolute result. Document abnormal observations, new neurological or respiratory features, compromised circulation and other disease-specific warning signs. Seek timely senior or emergency support when the trajectory is concerning. In this context, confirm that the patient is within the population for which the rule is appropriate and that all criteria are met.
How should repeated measurements be interpreted?
Selected adult pathways use age-adjusted D-dimer cut-offs for people older than 50 years. Trends become useful when comparable measurements were obtained using reliable methods and documented context. A change may reflect treatment, acute illness or measurement error. Interpret it together with symptoms, examination and relevant investigations rather than assuming it represents a single biological mechanism. In this context, check whether the local protocol uses conventional, age-adjusted or another validated threshold.
Does a test or scoring tool replace clinical judgement?
Pregnancy and the period after birth change disease prevalence, laboratory findings and imaging considerations. A score or test is a component of the assessment, not its conclusion. It should have a specified purpose, entry criteria and action threshold. Check the original guideline and laboratory method, and do not mix unrelated scoring systems or diagnostic cut-offs. In this context, apply an appropriate obstetric VTE pathway with multidisciplinary input and balanced imaging decisions.
What should be included in a handover?
When imaging is delayed, validated guidelines may advise interim anticoagulation for selected suspected VTE cases. Good handover includes the clinical question, relevant baseline, current concerns, investigations already performed, what remains uncertain, the planned review and who owns it. Give the receiving team the information needed to identify worsening symptoms or a delayed test result. In this context, follow the actual NICE or local pathway and document the clinical reasoning and re-evaluation plan.
How should cited guidance be used?
New hypotension, increasing hypoxia or syncope can change the patient from a routine investigation to emergency care. References support the clinical framework but must be checked for applicability and updates. They do not independently validate an individual diagnosis or confer approval on the article. A professional reviewer should verify the important claims against source recommendations before clinical publication. In this context, repeat observations and escalate when trajectory or new data change the assessment.
What makes a safe follow-up and safety-net plan?
Suspected PE can present with shock, syncope, severe hypoxaemia or circulatory collapse requiring immediate care. Safety-net advice should identify symptoms that demand urgent assessment and clarify the appropriate contact route. The plan should be proportionate to risk, accessible to the person receiving it and revised when new information changes the clinical picture. In this context, assess airway, breathing, circulation, oxygenation and haemodynamics before using diagnostic exclusion algorithms.